Iovance Biotherapeutics (IOVA) Amortizatization of Intangibles (2011 - 2026)

Iovance Biotherapeutics (IOVA) has reported Amortizatization of Intangibles for 13 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 47.81% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $6.2 million (down 38.68% YoY), while the FY2025 annual figure was $7.2 million, down 29.81% from the prior year.
• Amortizatization of Intangibles fell to $1.1 million in Q1 2026 per IOVA's latest filing, from $1.3 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $2.8 million in Q4 2024 and bottomed at -$541000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $1.3 million in 2025.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles surged 2131.71% — and 2025, when it slumped 51.59%.
• Iovance Biotherapeutics' Amortizatization of Intangibles stood at $654000.0 in 2022, then surged by 164.07% to $1.7 million in 2023, then soared by 60.51% to $2.8 million in 2024, then sank by 51.59% to $1.3 million in 2025, then slipped by 16.54% to $1.1 million in 2026.
• Business Quant data shows IOVA's Amortizatization of Intangibles at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.